Correlation Between Seer and Serina Therapeutics
Can any of the company-specific risk be diversified away by investing in both Seer and Serina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and Serina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seer Inc and Serina Therapeutics, you can compare the effects of market volatilities on Seer and Serina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of Serina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and Serina Therapeutics.
Diversification Opportunities for Seer and Serina Therapeutics
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Seer and Serina is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and Serina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Serina Therapeutics and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with Serina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Serina Therapeutics has no effect on the direction of Seer i.e., Seer and Serina Therapeutics go up and down completely randomly.
Pair Corralation between Seer and Serina Therapeutics
Given the investment horizon of 90 days Seer Inc is expected to generate 0.47 times more return on investment than Serina Therapeutics. However, Seer Inc is 2.11 times less risky than Serina Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Serina Therapeutics is currently generating about -0.22 per unit of risk. If you would invest 231.00 in Seer Inc on October 21, 2024 and sell it today you would lose (2.00) from holding Seer Inc or give up 0.87% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Seer Inc vs. Serina Therapeutics
Performance |
Timeline |
Seer Inc |
Serina Therapeutics |
Seer and Serina Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seer and Serina Therapeutics
The main advantage of trading using opposite Seer and Serina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, Serina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will offset losses from the drop in Serina Therapeutics' long position.Seer vs. Oric Pharmaceuticals | Seer vs. Anebulo Pharmaceuticals | Seer vs. Cullinan Oncology LLC | Seer vs. C4 Therapeutics |
Serina Therapeutics vs. NETGEAR | Serina Therapeutics vs. Weibo Corp | Serina Therapeutics vs. Tower Semiconductor | Serina Therapeutics vs. CTS Corporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |